S100A6 Overexpression Is Associated with Poor Prognosis and Is Epigenetically Up-Regulated in Gastric Cancer
- 31 August 2010
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 177 (2), 586-597
- https://doi.org/10.2353/ajpath.2010.091217
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motilityBritish Journal of Cancer, 2009
- Expression of S100A6 in Cardiac Myocytes Limits Apoptosis Induced by Tumor Necrosis Factor-αPublished by Elsevier BV ,2008
- Hsp70 is a new target of Sgt1—an interaction modulated by S100A6Biochemical and Biophysical Research Communications, 2007
- Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissueMolecular Carcinogenesis, 2006
- Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profilingOncogene, 2003
- Differential expression of the Ca2+ binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosaEuropean Journal of Cancer, 2000
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- The language of covalent histone modificationsNature, 2000
- Ca2+-Dependent Binding of Calcyclin to Muscle TropomyosinBiochemical and Biophysical Research Communications, 1996
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987